Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2021-10-28 2021-10-28
Drug Identification Number 02241284 02241284
Brand name INFANRIX-IPV INFANRIX-IPV
Common or Proper name Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I TETANUS TOXOID DIPHTHERIA TOXOID PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I TETANUS TOXOID DIPHTHERIA TOXOID PERTACTIN FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID
Strength(s) 32UNIT 8UNIT 40UNIT 40UNIT 30UNIT 8MCG 25MCG 25MCG 32UNIT 8UNIT 40UNIT 40UNIT 30UNIT 8MCG 25MCG 25MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size All pack sizes / Tous les formats All pack sizes / Tous les formats
ATC code J07CA J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-10-26 2021-10-26
Remaining supply date 2017-09-30 2017-09-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments